CIK 0000899923
- Accelerated filer
MYRIAD GENETICS INC
Sign in to watch- Ticker
- MYGN
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 870494517
- Phone
- +1 801-584-3600
- Business address
- 322 NORTH 2200 WEST, SALT LAKE CITY, UT, 84116
- Former names
- MYRIAD GENETICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-08-05 | LANCHBURY JERRY S Chief Scientific Officer | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −28,225 | 80,000 | ||
| 2021-08-04 | LANCHBURY JERRY S Chief Scientific Officer | Exercise or conversion | +38,225 | $27.07 | $1.0M | 270,775 |
| 2021-08-04 | LANCHBURY JERRY S Chief Scientific Officer | Sale | −38,225 | $35.24 | $1.3M | 232,550 |
| 2021-08-04 | LANCHBURY JERRY S Chief Scientific Officer | Exercise or conversion | +11,775 | $27.07 | $319K | 244,325 |
| 2021-08-04 | LANCHBURY JERRY S Chief Scientific Officer | Sale | −11,775 | $35.57 | $419K | 232,550 |
| 2021-08-04 | LANCHBURY JERRY S Chief Scientific Officer | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −38,225 | 120,000 | ||
| 2021-08-04 | LANCHBURY JERRY S Chief Scientific Officer | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −11,775 | 108,225 | ||
| 2021-08-03 | Riggsbee Richard Bryan Chief Financial Officer | Sale | −14,983 | $35.14 | $526K | 324,942 |
| 2021-08-03 | LANGER DENNIS Director | Exercise or conversion | +30,000 | $25.39 | $762K | 119,527 |
| 2021-08-03 | LANGER DENNIS Director | Sale | −30,000 | $34.75 | $1.0M | 89,527 |
| 2021-08-03 | LANGER DENNIS Director | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −30,000 | 0 | ||
| 2021-08-03 | LANCHBURY JERRY S Chief Scientific Officer | Exercise or conversion | +16,225 | $26.49 | $430K | 248,775 |
| 2021-08-03 | LANCHBURY JERRY S Chief Scientific Officer | Sale | −16,225 | $33.99 | $551K | 232,550 |
| 2021-08-03 | LANCHBURY JERRY S Chief Scientific Officer | Exercise or conversion | +1,775 | $27.07 | $48K | 234,325 |
| 2021-08-03 | LANCHBURY JERRY S Chief Scientific Officer | Sale | −1,775 | $35.07 | $62K | 232,550 |
| 2021-08-03 | LANCHBURY JERRY S Chief Scientific Officer | Exercise or conversion | +27,830 | $23.98 | $667K | 260,380 |
| 2021-08-03 | LANCHBURY JERRY S Chief Scientific Officer | Sale | −27,830 | $34.00 | $946K | 232,550 |
| 2021-08-03 | LANCHBURY JERRY S Chief Scientific Officer | Exercise or conversion | +4,170 | $23.98 | $100K | 236,720 |
| 2021-08-03 | LANCHBURY JERRY S Chief Scientific Officer | Sale | −4,170 | $34.00 | $142K | 232,550 |
| 2021-08-03 | LANCHBURY JERRY S Chief Scientific Officer | Exercise or conversion · Incentive Stock Option (right to buy) | −4,170 | 0 |
Page 24 of 35 · 689 trades